House Medicaid Reform Could “Refine” Average Manufacturer Price
A House Energy & Commerce Committee draft document on Medicaid reform recommends revising the definition of average manufacturer price to better suit pharmacy reimbursement
You may also be interested in...
The Centers for Medicare & Medicaid Services should issue guidance on how drug manufacturers determine pricing, the Medicaid Commission's reform proposal recommends
Medicaid drug reimbursement based on average manufacturer price or average sales price could create "barriers" to wholesalers receiving the payments they typically are paid by manufacturers, Cardinal VP-Professional & Government Relations Connie Woodburn told the National Association of Chain Drug Stores' Pharmacy & Technology Conference Aug. 30 in San Diego
Giving states more federal funding to improve Medicaid drug utilization review procedures would save $470 mil. in 2006 and $3.44 bil. over five years, the National Association of Chain Drug Stores asserted